Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Elutia Inc. before investing.

In this article, we go over a few key elements for understanding Elutia Inc.’s stock price such as:

• Elutia Inc.’s current stock price and volume
• Why Elutia Inc.’s stock price changed recently
• Upgrades and downgrades for ELUT from analysts
• ELUT’s stock price momentum as measured by its relative strength

About Elutia Inc. (ELUT)

Before we jump into Elutia Inc.’s stock price, history, target price and what caused it to recently , let’s take a look at some background.

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.

Want to learn more about Elutia Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Elutia Inc..

Elutia Inc.’s Stock Price as of Market Close

As of September 02, 2026, 4:00 PM, CST, Elutia Inc.’s stock price was $0.845.

Elutia Inc. is 0% from its previous closing price of $0.845.

During the last market session, Elutia Inc.’s stock traded between $0.840 and $0.940. Currently, there are approximately 44.22 million shares outstanding for Elutia Inc..

Elutia Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Elutia Inc. Stock Price History

Elutia Inc.’s (ELUT) price is currently down 2.16% so far this month.

During the month of September, Elutia Inc.’s stock price has reached a high of $0.950 and a low of $0.840.

Over the last year, Elutia Inc. has hit prices as high as $2.132 and as low as $0.500. Year to date, Elutia Inc.’s stock is up 22.04%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Elutia Inc. Stock’s Price to ?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 02, 2026, there were analysts who downgraded Elutia Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Elutia Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Elutia Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Elutia Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Elutia Inc. (ELUT) by visiting AAII Stock Evaluator.

Relative Price Strength of Elutia Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 02, 2026, Elutia Inc. has a weighted four-quarter relative price strength of -10.50%, which translates to a Momentum Score of 22 and is considered to be Weak.

Want to learn more about how Elutia Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Elutia Inc. Stock Price: Bottom Line

As of September 2, 2026, Elutia Inc.’s stock price is $0.845, which is 0% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Elutia Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.